Association of Human Milk Antibody With SARS-CoV-2 Infection vs mRNA Vaccination

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 10, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2021.4897?guestAccessKey=4d39c881-1df7-4817-8ee5-af4d6a255fde&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111021

 

What The Study Did: Researchers compared the pattern and neutralizing activity of anti–SARS-CoV-2 antibodies in human milk in this study of 77 lactating parents, 47 parents had a COVID-19 diagnosis and 30 parents were vaccinated with a COVID-19 messenger RNA vaccine.

Authors: Kirsi Järvinen, M.D., Ph.D., of the University of Rochester School of Medicine and Dentistry in Rochester, New York, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2021.4897)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.